THE JOHNS HOPKINS HOSPITAL 
BALTIMORE, MARYLAND 21203 
Department of Pediatrics 
9 September 1980 
Dr. William Gartland 
Chief, Office of Recombinant DNA Activities 
National Institutes of Health 
Bldg. 31, Room 4A-52 
Bethesda, Maryland 20205 
Dear Dr. Gartland: 
This letter is written to support Dr. Singer's proposal to stream- 
line recombinant DNA research guidelines by eliminating NIH review, 
registration, and approval for all experiments assigned containment 
conditions. The proposal makes great sense since individual investi- 
gators will still be responsible for notifying IBCs of their activities. 
Sincerely yours. 
Haig H. Kazazian, Jr., M.D. 
Professor of Pediatrics 
HHK/bme 
[ 299 ] 
